Hofseth BioCare lingers in the red despite spike in revenues

The company is continuing to take important steps forward when it comes to developing Hofseth BioCare into a 'true biotech company.'

Roger Hofseth i Hofseth International
Roger Hofseth i Hofseth International
Published 28 August 2020, 08:15Updated 28 August 2020, 12:26